Shares in the Indianapolis-based drugmaker are setting new records almost every day, due to investor excitement over the company’s new drugs for obesity and diabetes, two health conditions that plague America.
EMS providers say insurance stinginess is complicating their financial stability and forcing them to hand big bills to unwitting Hoosiers.
A major Louisiana health insurer’s plan to reorganize and sell itself to Indianapolis-based insurance giant Elevance Health was shelved after critics of the sale voiced various concerns over the proposal.
The U.S. Food and Drug Administration designated psilocybin as a “breakthrough therapy” for treatment-resistant depression in 2018 and for major depressive disorder in 2019.
An Israeli company has firmed up plans for a new isotope manufacturing plant in Westfield in what is becoming a scramble in a red-hot local market for nuclear-medicine facilities.
Estimates predict that Indiana would need an additional 5,000 nurses by 2031, equal to graduating an additional 1,300 nurses each year until that time, according to the Indiana Hospital Association.
As Novo and Lilly fight to dominate the market in weight-loss drugs, gaining an edge in manufacturing power is emerging as a new front. Both drugmakers are racing to secure the highly specialized plants that can churn out enough of their top-selling drugs to keep up with demand.
Indianapolis-based Marathon said the merger will extend services to 2.5 million eligible patients and more than 630 U.S. employer and union-sponsored clients.
At 6-foot-11, former Indiana Pacers center Scot Pollard’s size helped him play more than a decade in the NBA, earning him a championship ring with the 2008 Boston Celtics. Now, it might be killing him.
Several Indiana employers, universities and health care organizations have launched the Indiana Business Health Collaborative, a new partnership that wants to improve Indiana’s health profile through private-sector solutions.
A state legislative committee held a nearly eight-hour meeting to consider the proposed sale of Blue Cross and Blue Shield of Louisiana to Indianapolis-based Elevance.
Indianapolis-based Eli Lilly and Co. and Switzerland-based Novartis were the most active acquirers in the past 12 months, with seven and six deals respectively, according to data compiled by Bloomberg.
The Catalent biologics campus covers 62 acres and has four buildings totaling almost one million square feet. The facility was opened by Cook Pharmica in 2004 and acquired by Catalent in 2017.
The Boston-based biotech company with large operations in Indiana has raised more than a half-billion dollars over its eight-year history.
Green’s new journey to becoming a leading advocate for wiping out tuberculosis worldwide has its roots in another of his philanthropic interests: the health of mothers and infants in Sierra Leone.
Indiana will receive more than $7.6 million from the settlement with Publicis Health to help address the opioid crisis.
Lilly said it was working closely with the FDA and the “situation does not affect the quality, safety or supply of any current or planned Lilly products in the marketplace.”
The bill would would prohibit health insurers from requiring prior authorization for routine medical services, federally approved prescription drugs, emergency health care and other services.
Hospitals in Marion County have reported a surge in patients, placing many of them at capacity, the health department said.
The conservative Braun and the liberal Sanders might have more in common that meets the eye, with a growing list of issues they have both supported.
